Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
High Risk
100%
Patient Management
100%
Sudden Cardiac Death Risk
100%
Flecainide
100%
Flecainide Acetate
100%
Ventricular Tachycardia
60%
Follow-up Time
20%
Clinical Efficacy
20%
Ataxia
20%
Life-threatening
20%
Sinus Bradycardia
20%
Cardiac Effects
20%
Congestive Heart Failure
20%
Numbness
20%
Holter Monitoring
20%
Antiarrhythmic Agents
20%
Cardiopulmonary Resuscitation
20%
Ventricular Arrhythmia
20%
Syncope
20%
Angiographic Findings
20%
Left Ventricular Dysfunction
20%
Left Bundle Branch Block
20%
Cerebral Stroke
20%
Noncardiac
20%
Blurred Vision
20%
Complete Elimination
20%
Complete Atrioventricular Block
20%
Holter
20%
Incessant Tachycardia
20%
Antiarrhythmic Effect
20%
Depressed Left Ventricular Function
20%
Low Ejection Fraction
20%
Significant Coronary Artery Disease
20%
Left Ventricular Ejection
20%
Medicine and Dentistry
Ventricular Tachycardia
100%
Sudden Cardiac Death
100%
Flecainide
100%
Flecainide Acetate
100%
Heart Left Ventricle Function
20%
Coronary Artery Disease
20%
Apoplexy
20%
Ataxia
20%
Ejection Fraction
20%
Sinus Bradycardia
20%
Paresthesia
20%
Antiarrhythmic Agent
20%
Resuscitation
20%
Faintness
20%
Congestive Heart Failure
20%
Heart Left Ventricle Failure
20%
Left Bundle Branch Block
20%
Holter Monitoring
20%
Blurred Vision
20%
Third-Degree Atrioventricular Block
20%
Cardiac Side Effect
20%
Heart Ventricle Ejection
20%
Side Effect
20%
Pharmacology, Toxicology and Pharmaceutical Science
Heart Ventricle Tachycardia
100%
Flecainide
100%
Sudden Cardiac Death
100%
Flecainide Acetate
100%
Coronary Artery Disease
20%
Elimination
20%
Sinus Bradycardia
20%
Congestive Heart Failure
20%
Paresthesia
20%
Antiarrhythmic Agent
20%
Cerebrovascular Accident
20%
Ataxia
20%
Faintness
20%
Heart Left Ventricle Failure
20%
Blurred Vision
20%
Complete Heart Block
20%
Heart Left Bundle Branch Block
20%
Cardiac Side Effect
20%
Side Effect
20%